Lara Vasari

Dr. Lara Vasari

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2024 in Life
Verified
Journal Article
Open access
PDF file
Ružica Jurakić TončićRužica Jurakić Tončić
Ružica Jurakić Tončić
LVLara Vasari
Lara Vasari
DBDaška Štulhofer Buzina
Daška Štulhofer Buzina
DDDaniela Ledić Drvar
Daniela Ledić Drvar
MPMikela Petković
Mikela Petković
RČRomana Čeović
Romana Čeović
The prognosis, outcome, and overall survival of melanoma patients improve with early diagnosis which has been facilitated in the past few decades with the introduction of dermoscopy. Further advancements in dermoscopic research, coupled with skilled, educated dermatologists in dermoscopy, have contributed to timely diagnoses. However, detecting amelanotic and hypomelanotic melanoma remains a challenge even to the most skilled experts because these melanomas can mimic inflammatory diseases, numerous benign lesions, and non-melanoma skin cancers. The list of the possible differential diagnoses can be long. Melanoma prediction without the pigment relies only on vascular criteria, and all classic dermoscopic algorithms have failed to fulfill our expectations. In fact, the diagnosis of amelanotic and hypomelanotic melanomas is very challenging, which is why every tool in detecting these lesions is of significance. This review aims to explore the current knowledge and the literature on the possibility of detecting amelanotic/hypomelanotic melanomas using sequential monitoring with digital dermoscopy and total body skin photography.

18 November 2025 in Journal of Vascular Diseases
Verified
Journal Article
Open access
PDF file
LVLara Vasari
Lara Vasari
VMVedrana Mužić
Vedrana Mužić
SKSandra Marinović Kulišić
Sandra Marinović Kulišić
DBDaška Štulhofer Buzina
Daška Štulhofer Buzina
EREndi Radović
Endi Radović
ALAna Lamza
Ana Lamza
Chronic venous insufficiency (CVI) is a common peripheral vascular condition characterised by the retrograde blood flow in the lower extremities and its consequences such as oedema and other complications. Clinical severity of CVI is assessed according to the CEAP (Clinical, Etiological, Anatomic, and Physiopathologic) classification, which recognises seven grades of increasing clinical severity (C0–C6). Compression therapy aims to accelerate vein, lymph, and microcirculation flow and therefore reduce chronic nonbacterial inflammation and oedema of the extremities. In accordance with the elasticity and stiffness, compression bandages and garments are divided into short-stretch and long-stretch compression materials. Compression therapy is applicable in all stages of CVI. Moreover, compression therapy in conjunction with physical therapy and lifestyle modifications is more effective in reducing oedema, preventing venous distension, and reducing venous wall tension, all while improving calf muscle pump function. Physical therapy in CVI treatment combines everyday lifestyle modifications, physical activity, medical exercise, sports activity, hydrotherapy, and electrotherapy. Therefore, physical therapy is used either for prevention or either for therapeutic purposes in CVI. For grades CEAP C0–C2, preventive measures consist of education and counselling, medical exercise and general fitness, and sports and physical activities. However, for therapy in grades CEAP C3–C6, medical exercise and a specific rehabilitation programme, manual lymphatic drainage and massage, balneotherapy, and electrotherapy are recommended.

30 January 2026 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
LVLara Vasari
Lara Vasari
LSLuka Simetić
Luka Simetić
SKSanja Kusačić Kuna
Sanja Kusačić Kuna
DBDaška Štulhofer Buzina
Daška Štulhofer Buzina